- Home
- ALLO vs HPP Comparison
ALLO vs HPP Comparison
Compare ALLO & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | HPP |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | 607 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.4M | 609.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALLO | HPP |
|---|---|---|
| Price | $2.17 | $12.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | $8.35 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 6.1M | 1.2M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | $6.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $1.67 |
| 52 Week High | $4.46 | $14.95 |
Technical Indicators
Market Signals| Indicator | ALLO | HPP |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 65.51 |
| Support Level | $2.12 | $10.18 |
| Resistance Level | $2.71 | $12.28 |
| Average True Range (ATR) | 0.14 | 0.68 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 57.27 | 73.36 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a vertically integrated real estate investment trust offering end-to-end real estate solutions for dynamic tenants in the synergistic, converging and secular growth industries of tech and media. It acquires, repositions, develops and operates sustainable high-quality office studio properties in high-barrier-to-entry tech and media epicenters. Its primary investment markets include Los Angeles, the San Francisco Bay Area, Seattle, New York and Vancouver, British Columbia. Its segments include Office properties and related operations and Studio properties and related operations. The majority of the revenue is derived from Office properties and related operations segment.